Strategies for structure elucidation using Ultrafast Mass Spectrometry (UFMS): Using nMS2 as an alternative to MS3

Posters | 2013 | ShimadzuInstrumentation
LC/MS, LC/MS/MS, LC/QQQ
Industries
Manufacturer
Shimadzu

Summary

Importance of the Topic


The ability to rapidly elucidate molecular structures under fast chromatography conditions is critical in pharmaceutical analysis and metabolite identification It enables high throughput screening real time decision making and improved sensitivity when detecting low abundant species under time constraints

Objectives and Study Overview


This study evaluated an Ultrafast Tandem Mass Spectrometric method called nMS2 as an alternative to conventional MS3 for structure elucidation The goal was to demonstrate that multiple fragmentation spectra could be acquired from the same precursor ion at varying collision energies in sub 200 millisecond cycles

Methodology and Instrumentation


The method used a Shimadzu Nexera X2 UHPLC system coupled to an LCMS 8040 ultrafast triple quadrupole mass spectrometer Chromatographic separation was performed with water and methanol both containing 1 percent formic acid at a flow rate of 0.5 mL per minute Precursor ions were isolated in the first quadrupole and subjected to collision induced dissociation across three to five collision energies in rapid succession with polarity switching in 15 ms Spectra were acquired across m/z 50 to 350 at a scan rate of 15000 u per second This approach generated up to nine parallel MS2 channels triggered by scheduled MRM events completing all spectral acquisitions within 100 to 200 ms

Main Results and Discussion


Applying nMS2 to pharmaceutical standards such as oseltamivir metoclopramide ciprofloxacin and modafinil produced arrays of complementary fragment spectra Mechanistic pathways from low energy neutral losses to high energy aromatic rearrangements were captured Simultaneous acquisition of positive and negative ion fragments improved structural information density compared to single polarity MS3 The method maintained UHPLC peak definition with 25 data points over a five second peak and preserved sensitivity by avoiding sequential generation of daughter ions as in MS3

Benefits and Practical Applications


This ultrafast nMS2 strategy offers several advantages
  • Enhanced sensitivity since fragments derive from the same abundant parent ion
  • Improved structural insight via multiple collision energies and polarity states
  • Retention of chromatographic resolution through rapid cycle times
  • On the fly detection and identification of novel metabolites or impurities

Future Trends and Potential Applications


Further development may integrate real time data analysis and automated spectral interpretation Algorithms for deconvoluting multiplexed spectra could expand the approach to complex mixtures Applications may extend to environmental screening proteomics and lipidomics where high throughput structure elucidation is desired

Conclusion


nMS2 with ultrafast mass spectrometry is a viable alternative to MS3 for rapid structure elucidation It combines high sensitivity with rich spectral data while preserving fast chromatographic separations This method enables real time analysis of pharmaceuticals and their metabolites with enhanced structural discrimination

Reference


Paul Wynne Nigel Grieves Niron Van John Hewetson Bruce Fraser Strategies for structure elucidation using Ultrafast Mass Spectrometry (UFMS) Using nMS2 as an alternative to MS3 ASMS 2013 ThP-116 Shimadzu

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Toggle
Strategies for structure elucidation using Ultrafast Mass Spectrometry (UFMS): Using nMS2 as an alternative to MS3
PO-CON1346E Strategies for structure elucidation using Ultrafast Mass Spectrometry (UFMS): Using nMS2 as an alternative to MS3 ASMS 2013 ThP-116 Paul Wynne, Nigel Grieves, Niron Van, John Hewetson and Bruce Fraser Shimadzu Australasia, Rydalmere, New South Wales; Rowville, Victoria ,…
Key words
modafinil, modafinilesi, esiparent, parentultrafast, ultrafastelucidation, elucidationfragmentation, fragmentationstrategies, strategiesstructure, structureion, ionpis, pispathways, pathwaysmass, massloss, lossspectra, spectrafragmentationc
Fundamental Guide to Liquid Chromatography Mass Spectrometry (LCMS)
C10G-E065A Fundamental Guide to Liquid Chromatography Mass Spectrometry (LCMS) © Shimadzu Corporation First Edition: October, 2018 Updated on: March, 2019 For Research Use Only. Not for use in diagnostic procedures. This publication may contain references to products that are not…
Key words
lcms, lcmsion, ionions, ionsmass, massionization, ionizationtof, tofhigh, highquadrupole, quadrupoletrap, trapphase, phasemagnetic, magneticflight, flightesi, esiclick, clickanalysis
Shimadzu Fundamental Guide to Liquid Chromatography Mass Spectrometry (LCMS)
C10G-E065A Fundamental Guide to Liquid Chromatography Mass Spectrometry (LCMS) © Shimadzu Corporation First Edition: October, 2018 Updated on: March, 2019 For Research Use Only. Not for use in diagnostic procedures. This publication may contain references to products that are not…
Key words
lcms, lcmsion, ionions, ionsmass, massionization, ionizationtof, tofquadrupole, quadrupolehigh, hightrap, trapphase, phasemagnetic, magneticesi, esiflight, flightclick, clickanalysis
Search for What’s Missing: Unknown Compound Characterization Using LC-MS
Search for What’s Missing: Unknown Compound Characterization Using LC-MS Kate Comstock Sr. Marketing Specialist, Pharma/Biopharma Marketing The world leader in serving science Small Molecule Structure Analysis Small molecule structure analysis encompasses broad applications: Pharmaceutical, metabolomics, food & environmental, clinical, forensic,…
Key words
acquirex, acquirexmsn, msnhydrolysis, hydrolysisstructure, structureworkflow, workfloworbitrap, orbitrapamprenavir, amprenavirmass, massoxidation, oxidationmetabolites, metabolitesdata, dataisotope, isotopemolecule, moleculeparent, parentmzcloud
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike